Moomoo AI 已提取核心信息
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Altimmune, Inc. [ALT] 首席医疗官马修·斯科特·哈里斯于2024年2月1日和2日完成了一系列股票交易。哈里斯行使期权免费收购了总共13,941股普通股。同时，他出售了4,133股股票以支付行使价或纳税义务，销售价格在每股9.32美元至9.88美元之间，总市值为39,528.12美元。在这些交易之后，哈里斯直接持有总计53,633股Altimmune股票。
Altimmune, Inc. [ALT] 首席医疗官马修·斯科特·哈里斯于2024年2月1日和2日完成了一系列股票交易。哈里斯行使期权免费收购了总共13,941股普通股。同时，他出售了4,133股股票以支付行使价或纳税义务，销售价格在每股9.32美元至9.88美元之间，总市值为39,528.12美元。在这些交易之后，哈里斯直接持有总计53,633股Altimmune股票。
有用
没用